Interoperabilität
The company aims to enhance interoperability of its digital health applications to give customers full data control.

Kranus Health provides virtual care in urology and develops integrated care therapies for indications ranging from andrology to uro-oncology.
kranushealth.comCrawled Nov 4, 2026
The company aims to enhance interoperability of its digital health applications to give customers full data control.
Kompatibilität mit iOS und Android
The page explains how to start a Kranus therapy by uploading a prescription for Lutera, Edera, or Mictera, covered by health insurance.
Users can download the manual for their respective product here.
Silva V, Grande AJ, Peccin MS. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2019 Apr 6;4(4):CD012044. doi: 10.1002/14651858.CD012044.pub2. PMID: 30953341; PMCID: PMC6450803.
The ProPED study, conducted with the Universitätsklinikum Münster, evaluates the effectiveness of app-based therapy for psychogenic erectile dysfunction.
The page examines how digital health applications can improve guideline compliance for erectile dysfunction treatment.
Berlin / Munich, 20th of February 2025 Munich/Berlin 02/20/2025 – Urinary incontinence is a taboo subject that affects many women and causes considerable psychosocial burden. To cope successfully, a concept is needed that strengthens physicians and patients alike. The digital
Thanks to convincing clinical study results: First digital health app (DiGA) to treat erection problems and their causes is now permanently reimbursed by health insurers.
The page provides the latest information on urological therapies.
The page offers the latest information on urological therapies.
The page offers current information on urological therapies.
Kranus Health, the company behind the world's first prescription digital therapeutic to treat erectile dysfunction, announces the successful closing of its Series A at over 6.5 million US dollars.
The company develops digital therapeutics, online patient journeys, and telemedicine solutions for urology in Germany and globally.
Kranus Health’s scientific committee includes recognized medical experts with extensive clinical and scientific experience.
The medical advisory board of Kranus Health consists of highly qualified and renowned physicians with many years of clinical and scientific experience.
Kranus Health’s medical advisory board consists of highly qualified and renowned physicians with long-term clinical and scientific experience.
Haftung für Inhalte
The company’s therapies are available in select countries.
The company focuses on advancing urological care for erectile dysfunction, frequent urination, and female incontinence.
The company shapes the future of urological care for erectile dysfunction, frequent urination, and female incontinence.
The company shapes the future of urological care for erectile dysfunction, frequent urination, and female incontinence.
The page contains the privacy policy for the website.
The page provides privacy policies and terms of use for Kranus Edera, Kranus Lutera, and Kranus Mictera.
Legal notice of Kranus Health GmbH
The general terms and conditions for Kranus Health GmbH’s digital health application programs.
Kranus Health expands its operations into France, leveraging the Paris Region’s regulatory clarity and ecosystem for Digital Therapeutics (DTx). The company highlights France’s structured framework as a key advantage for deploying DTx solutions. Paris Region’s concentration of industry stakeholders further supports Kranus Health’s growth strategy.
Kranus Health secures an extra **4.6 million euros** in its ongoing funding round, bringing the total to **18.4 million euros (20 million USD)**. The Munich-based startup uses digital solutions to strengthen its focus in **urology**. The company plans to leverage the funds to expand its market presence and operations.
Kranus Health secures an additional €14.3 million ($15 million) in Series A funding to advance its digital urology therapy solutions. The Munich-based healthtech startup focuses on innovative treatment concepts in urology, expanding its financial backing to support development and scaling efforts.
Kranus Health secures **$6.5 million** in funding to expand its digital therapy offerings for men’s health. The Berlin-based startup launched its **Edera app** in January, targeting scalable solutions in men’s healthtech. Investments will support research and development of additional digital therapies.
Kranus Health secures over **€6 million** in funding to develop a digital therapy platform for men’s health issues, addressing taboo topics with a tech-driven, holistic approach. The startup focuses on solutions akin to digital alternatives for conditions traditionally treated with medications like Viagra. By leveraging digital tools, Kranus aims to reduce stigma and improve accessibility for underserved patient groups.